Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank_resource:DB00427_DB01173_nanopub.RAD9lKLKNvbcU403AGTHJ_4MaY2CDh2IUREbInhA3Qmjs#assertion>. }
Showing items 1 to 6 of
6
with 100 items per page.
- drugbank_resource:DB00427_DB01173 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB00427_DB01173 label "DDI between Triprolidine and Orphenadrine - Triprolidine and Orphenadrine, two anticholinergics, may cause additive anticholinergic effects and enhance their adverse/toxic effects. Additive CNS depressant effects may also occur. Monitor for enhanced anticholinergic and CNS depressant effects. [drugbank_resource:DB00427_DB01173]" assertion.
- drugbank_resource:DB00427_DB01173 identifier "drugbank_resource:DB00427_DB01173" assertion.
- drugbank_resource:DB00427_DB01173 title "DDI between Triprolidine and Orphenadrine - Triprolidine and Orphenadrine, two anticholinergics, may cause additive anticholinergic effects and enhance their adverse/toxic effects. Additive CNS depressant effects may also occur. Monitor for enhanced anticholinergic and CNS depressant effects." assertion.
- drugbank:DB00427 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00427_DB01173 assertion.
- drugbank:DB01173 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00427_DB01173 assertion.